AKERO THERAPEUTICS INC (AKRO) Institutional Shareholders
AKERO THERAPEUTICS INC (AKRO) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended September 30, 2025. The institutional investors covered on this page collectively reported approximately $384,873 in AKRO holdings during the latest filing period.
Op Asset Management Ltd is currently the largest disclosed institutional shareholder of AKRO tracked by InsiderSet, reporting ownership valued at approximately $384,873 in its September 30, 2025 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $442,992.9, representing an estimated gain of +15.10% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed AKRO value among the investors covered in this analysis. Major shareholders include Op Asset Management Ltd, and several other long-term asset managers with concentrated positions in AKERO THERAPEUTICS INC (AKRO).
This page ranks the largest institutional AKRO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
1
Total Reported Value
$384,873
Largest Holder
Op Asset Management Ltd
Largest Position
$384,873
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2025
New Institutional Positions
8
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Op Asset Management Ltd | 0.01% | 8,106 | $384,873 | $442,993 | +$58,120 | +15.10% |
Frequently asked questions about AKRO
Who owns the most AKRO stock?
The largest holders of AKRO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for AKERO THERAPEUTICS INC (AKRO).
Is AKRO widely held by superinvestors?
Many widely followed stocks like AKRO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AKRO is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.